iTeos Therapeutics's total assets for Q3 2024 were $723.08M, a decrease of -3.83% from the previous quarter. ITOS total liabilities were $91.39M for the fiscal quarter, a 3.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.